One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
Faricimab demonstrates favorable anatomical and functional outcomes with extended treatment intervals in a majority of patients with treatment-naïve nAMD, offering the potential of reduced treatment burden and the absence of retinal fluid in more than half of the subjects during the first year, while maintaining safety in a real-world setting.
Authors
- Christin Schild (ORCID: https://orcid.org/0000-0001-7705-1103)
- A Weinberger
- Nicolas Feltgen (ORCID: https://orcid.org/0000-0002-6857-3003)
- Moreno Menghini (ORCID: https://orcid.org/0000-0002-1432-2524)
- Marion R. Munk (ORCID: https://orcid.org/0000-0002-6227-2242)
- Andreas Ebneter (ORCID: https://orcid.org/0000-0001-6666-2558)
- Sandrine Zweifel (ORCID: https://orcid.org/0000-0001-7431-1774)
- Mariano Cozzi (ORCID: https://orcid.org/0000-0001-7777-2461)
- Katja Hatz (ORCID: https://orcid.org/0000-0003-2807-0310)
- Aude Ambresin (ORCID: https://orcid.org/0000-0002-6543-3400)
- Gábor Márk Somfai (ORCID: https://orcid.org/0000-0001-6329-442X)
- Gabriela Grimaldi (ORCID: https://orcid.org/0000-0003-2435-7867)
- Dmitri Artemiev
- Chiara Maria Eandi (ORCID: https://orcid.org/0000-0003-3656-1689)
- Jennifer Cattaneo (ORCID: https://orcid.org/0000-0002-3750-2886)
- Isabel B. Pfister (ORCID: https://orcid.org/0000-0001-8752-8390)
- Anne Tillmann
- Justus G. Garweg (ORCID: https://orcid.org/0000-0003-3973-5082)
- Jacqueline Fröhlich
- Richard Stillenmunkes
- Eva C de Oliveira Figueiredo
- Tahm Spitznagel
- Nicolò Bartolomeo (ORCID: https://orcid.org/0000-0001-9522-7176)
- Nils Schaerer
Institutions
- Semmelweis University (HU)
- Northwestern University (US)
- University of Bern (CH)
- University of Basel (CH)
- University of Zurich (CH)
- Kantonsspital St. Gallen (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- Berner Augenklinik am Lindenhofspital (CH)
- Ente Ospedaliero Cantonale (CH)
- University Hospital of Zurich (CH)
- Schulthess-Klinik (CH)
- Vista Klinik (CH)
- Fondation Asile des Aveugles (CH)
- Torino e-district (IT)
- Stadtspital Waid (CH)
- Orthopädische Praxis (DE)
- University of Turin (IT)
- Università della Svizzera italiana (CH)
- RWTH Aachen University (DE)
- Praxis (EE)
- University of Lausanne (CH)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1007/s40123-025-01252-6
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alimera Sciences
- Apellis Pharmaceuticals
- Carl Zeiss Meditec AG
- Astellas Pharma
- Allergan